As the COVID-19 pandemic drives pharmaceutical companies to increase the resiliency of their supply chains, pharmaceutical manufacturers are looking to multi-product facilities to meet in-creased demand. Pharmaceutical Manufacturing while utilizing multi-product facilities can lead to cost savings and reduced timelines, it can also present several challenges—the first and foremost being the risk of cross-contamination. […]
